Atlas Trials

Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies

Clinical trial NCT04670809 · UNKNOWN

Trial details

NCT number
NCT04670809
Sponsor
Nanjing Yoko Biomedical Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hypertensive Emergency
Start date
2020-07-27
Primary completion
2021-08-01
Enrollment
262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.